Skip to content

DENTEPHARMA

Absorbed by Dentius BV KBO/BCE: BE 0548.701.977 subsidiary of Dentcap

Last board

1 auditor, last change in 2023
Statutory auditor, permanent representative Nicolas Dumonceau
appointed by deed of 31-12-2021

Office holders in the KBO →

Mandates through the years

3 names, the dashed line is today
Earliermandate already running before its first mention
Mandates as a list
  • GRANT THORNTON BEDRIJFSREVISOREN - REVISEURS D'ENTREPRISES
    • Statutory auditor, appointed by deed of 31-12-2021, still in office
  • Dental Partners
    • Director, from 02-09-2021 to 30-08-2023
  • MuhannadAlBunni
    • Director, until 22-09-2021

Control

Consolidating parent
Equity €14.4m
Loss €9.3m in 2025 (loss €8.4m in 2024)
consolidates
This company
DENTEPHARMA
Equity €1.9m
Loss €47,635 in 2022

Capital

Capital
€248,600
Shares
100
Contribution per share
€2,486
Equity per share
€19,218 in 2022
Source
deed of 22-06-2023

Owners through the years

as the annual accounts name them
consolidates
Owners as a list

Older annual accounts also name 1 natural person.

Source: shareholder structure in its own accounts, parent in its own accounts

Capital transactions

Shareholders according to the deeds
Stated in the deed deed of 22-06-2023 ↗
Capital over time
  1. 22-06-2023 Capital stated in the deed · €248,600 · 100 shares

Next steps